Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Chendu DIAO Pharmaceutical Group clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Chendu DIAO Pharmaceutical Group as lead sponsor. Synced 17 Nov 2026
3Current trials
2Recruiting now
1Drug in these trials
1Trial register
At a glance

Chendu DIAO Pharmaceutical Group is the lead sponsor of 3 current clinical trials in our China register. 2 are recruiting patients now. The most common phase is Phase 3. The drugs named most often in its trials are DA-302168S. The most-studied condition is Overweight and Obesity.

ClinicalTrials.gov trials by status

  • Recruiting267%
  • Not yet open133%

Trials by phase

  • Phase 3133%
  • Phase 2133%
  • Phase 1133%
01

Clinical trials sponsored by Chendu DIAO Pharmaceutical Group

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
A Study of DA-302168S in Participants With Overweight/Obesity
NCT07629544 · ClinicalTrials.gov ↗ · Overweight and Obesity
Phase 3 Recruiting 2026-06 China
Pharmacokinetics, Safety, and Tolerability of DA-302168S Tablets in Participants With Varying Degrees of Renal Impairment and Normal Renal Function
NCT07938515 · ClinicalTrials.gov ↗ · Obesity & Overweight
Phase 1 Recruiting 2026-11 China
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes
NCT07755150 · ClinicalTrials.gov ↗ · Type 2 Diabetes Mellitus
Phase 2 Not yet open 2026-08 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Chendu DIAO Pharmaceutical Group trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Chendu DIAO Pharmaceutical Group trials

3 conditions
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China32

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Overweight and Obesity

SponsorTrials
Raquel Vilar López2
Universidad Autonoma de Baja California2
Wave Life Sciences USA1
Max Planck Institute for Human Cognitive and Brain Sciences1
Fundació Sant Joan de Déu1

Sponsors with the most current trials registered for this condition.

06

Questions about Chendu DIAO Pharmaceutical Group trials

How many clinical trials does Chendu DIAO Pharmaceutical Group sponsor?

Chendu DIAO Pharmaceutical Group is the lead sponsor of 3 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are Chendu DIAO Pharmaceutical Group trials recruiting?

Yes. 2 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Chendu DIAO Pharmaceutical Group testing?

Its current trials name 1 drug or biological as interventions. The most frequent are DA-302168S (3). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.